Publicacións nas que colabora con Francisco Orallo Cambeiro (19)

2013

  1. Cyclic AMP relaxation of rat aortic smooth muscle is mediated in part by decrease of depletion of intracellular Ca2+ stores and inhibition of capacitative calcium entry

    Vascular Pharmacology, Vol. 58, Núm. 1-2, pp. 98-104

2011

  1. Trans-resveratrol simultaneously increases cytoplasmic Ca 2+ levels and nitric oxide release in human endothelial cells

    Molecular Nutrition and Food Research, Vol. 55, Núm. 8, pp. 1237-1248

2008

  1. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca 2+ responses in endothelial cells

    British Journal of Pharmacology, Vol. 154, Núm. 1, pp. 82-92

2007

  1. Effects of (-)-epigallocatechin-3-gallate in Ca2+-permeable non-selective cation channels and voltage-operated Ca2+ channels in vascular smooth muscle cells

    Life Sciences, Vol. 80, Núm. 23, pp. 2147-2153

  2. Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

    European Journal of Pharmacology, Vol. 577, Núm. 1-3, pp. 91-99

2006

  1. Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta

    British Journal of Pharmacology, Vol. 147, Núm. 3, pp. 269-280

2005

  1. Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells

    Molecular Nutrition and Food Research, Vol. 49, Núm. 5, pp. 396-404

2004

  1. (-)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Núm. 5, pp. 496-506

2002

  1. Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 12, Núm. 5, pp. 783-786

2000

  1. Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro

    General Pharmacology: The Vascular System, Vol. 35, Núm. 2, pp. 95-105

  2. Synthesis and pharmacological evaluation of 2,3-dihydro-3-oxo-4H- thieno[3,4-e][1,2,4]thiadiazine 1,1-dioxides as voltage-dependent calcium channel blockers

    European Journal of Medicinal Chemistry, Vol. 35, Núm. 7-8, pp. 751-759

1998

  1. Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: Comparison with hydralazine

    General Pharmacology, Vol. 30, Núm. 2, pp. 201-207

1995

  1. Study of the in vivo and in vitro cardiovascular effects of (+)‐glaucine and N‐carbethoxysecoglaucine in rats

    British Journal of Pharmacology, Vol. 114, Núm. 7, pp. 1419-1427

1994

  1. Effects of hydralazine on contractile responses to α1 and α2-adrenoceptor agonists in isolated rubbed rat aorta

    General Pharmacology, Vol. 25, Núm. 1, pp. 165-172

  2. Pharmacological study of several effects of hydralazine in the bisected rat vas deferens

    European Journal of Pharmacology, Vol. 251, Núm. 1, pp. 83-90

1993

  1. Study of the mechanism of the relaxant action of (+)‐glaucine in rat vas deferens

    British Journal of Pharmacology, Vol. 110, Núm. 3, pp. 943-948

1992

  1. Effect of urethane on hydralazine-induced tachycardia in rats

    General Pharmacology, Vol. 23, Núm. 6, pp. 1143-1147

  2. Effects of Platelet Activating Factor on Contractions and Ca Influx Induced by Noradrenaline and Potassium in Rat Rubbed and Intact Aorta. Comparison with Its Hypotensive Effect in Anaesthetized Normotensive Rats

    Journal of Pharmacy and Pharmacology, Vol. 44, Núm. 4, pp. 344-348

  3. Role of the endothelial system in BAY K 8644 enantiomer and nifedipine vasomodulator action in rat aorta

    European Journal of Pharmacology, Vol. 221, Núm. 1, pp. 1-8